NATIONAL HEALTHCARE CORP (NHC) Stock Fundamental Analysis
NYSEARCA:NHC - American Stock Exchange - US6359061008 - Common Stock
Overall NHC gets a fundamental rating of 6 out of 10. We evaluated NHC against 108 industry peers in the Health Care Providers & Services industry. Both the health and profitability get an excellent rating, making NHC a very profitable company, without any liquidiy or solvency issues. NHC is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
NHC had positive earnings in the past year.
NHC had a positive operating cash flow in the past year.
NHC had positive earnings in each of the past 5 years.
NHC had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of NHC (7.95%) is better than 92.52% of its industry peers.
NHC's Return On Equity of 12.63% is amongst the best of the industry. NHC outperforms 81.31% of its industry peers.
NHC's Return On Invested Capital of 4.54% is in line compared to the rest of the industry. NHC outperforms 55.14% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for NHC is below the industry average of 8.27%.
The 3 year average ROIC (3.69%) for NHC is below the current ROIC(4.54%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.95% | ||
| ROE | 12.63% | ||
| ROIC | 4.54% |
ROA(3y)5.58%
ROA(5y)5.02%
ROE(3y)8.42%
ROE(5y)7.86%
ROIC(3y)3.69%
ROIC(5y)4.24%
1.3 Margins
With an excellent Profit Margin value of 10.03%, NHC belongs to the best of the industry, outperforming 95.33% of the companies in the same industry.
NHC's Profit Margin has been stable in the last couple of years.
The Operating Margin of NHC (6.55%) is better than 71.03% of its industry peers.
NHC's Operating Margin has declined in the last couple of years.
The Gross Margin of NHC (38.40%) is better than 65.42% of its industry peers.
In the last couple of years the Gross Margin of NHC has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.55% | ||
| PM (TTM) | 10.03% | ||
| GM | 38.4% |
OM growth 3Y-18.96%
OM growth 5Y-4.08%
PM growth 3Y12.84%
PM growth 5Y-0.55%
GM growth 3Y-3.79%
GM growth 5Y-1.51%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NHC is destroying value.
The number of shares outstanding for NHC remains at a similar level compared to 1 year ago.
Compared to 5 years ago, NHC has more shares outstanding
Compared to 1 year ago, NHC has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 3.37 indicates that NHC is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.37, NHC is doing good in the industry, outperforming 71.96% of the companies in the same industry.
The Debt to FCF ratio of NHC is 1.59, which is an excellent value as it means it would take NHC, only 1.59 years of fcf income to pay off all of its debts.
NHC's Debt to FCF ratio of 1.59 is amongst the best of the industry. NHC outperforms 85.98% of its industry peers.
NHC has a Debt/Equity ratio of 0.14. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.14, NHC is doing good in the industry, outperforming 71.03% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.14 | ||
| Debt/FCF | 1.59 | ||
| Altman-Z | 3.37 |
ROIC/WACC0.49
WACC9.24%
2.3 Liquidity
NHC has a Current Ratio of 1.80. This is a normal value and indicates that NHC is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.80, NHC is doing good in the industry, outperforming 66.36% of the companies in the same industry.
A Quick Ratio of 1.77 indicates that NHC should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.77, NHC is doing good in the industry, outperforming 66.36% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.8 | ||
| Quick Ratio | 1.77 |
3. Growth
3.1 Past
NHC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 173.50%, which is quite impressive.
Measured over the past 5 years, NHC shows a small growth in Earnings Per Share. The EPS has been growing by 2.39% on average per year.
NHC shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.10%.
The Revenue has been growing slightly by 3.09% on average over the past years.
EPS 1Y (TTM)173.5%
EPS 3Y16.83%
EPS 5Y2.39%
EPS Q2Q%302.89%
Revenue 1Y (TTM)12.1%
Revenue growth 3Y3.55%
Revenue growth 5Y3.09%
Sales Q2Q%17.93%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
NHC is valuated correctly with a Price/Earnings ratio of 12.36.
Compared to the rest of the industry, the Price/Earnings ratio of NHC indicates a rather cheap valuation: NHC is cheaper than 87.85% of the companies listed in the same industry.
NHC is valuated cheaply when we compare the Price/Earnings ratio to 27.94, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.36 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NHC indicates a somewhat cheap valuation: NHC is cheaper than 74.77% of the companies listed in the same industry.
79.44% of the companies in the same industry are more expensive than NHC, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.52 | ||
| EV/EBITDA | 10.17 |
4.3 Compensation for Growth
NHC has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)5.17
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
NHC has a Yearly Dividend Yield of 2.47%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.87, NHC pays a better dividend. On top of this NHC pays more dividend than 91.59% of the companies listed in the same industry.
NHC's Dividend Yield is comparable with the S&P500 average which is at 2.28.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.47% |
5.2 History
The dividend of NHC has a limited annual growth rate of 3.42%.
NHC has been paying a dividend for at least 10 years, so it has a reliable track record.
NHC has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)3.42%
Div Incr Years10
Div Non Decr Years10
5.3 Sustainability
NHC pays out 29.44% of its income as dividend. This is a sustainable payout ratio.
The dividend of NHC is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP29.44%
EPS Next 2YN/A
EPS Next 3YN/A
NATIONAL HEALTHCARE CORP
NYSEARCA:NHC (1/17/2025, 8:17:29 PM)
Premarket: 96.2 -2.45 (-2.48%)98.65
-0.16 (-0.16%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners57.11%
Inst Owner Change-0.02%
Ins Owners11.43%
Ins Owner Change-2.85%
Market Cap1.52B
Analysts60
Price TargetN/A
Short Float %3.37%
Short Ratio7.94
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.47% |
Yearly Dividend2.32
Dividend Growth(5Y)3.42%
DP29.44%
Div Incr Years10
Div Non Decr Years10
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.36 | ||
| Fwd PE | N/A | ||
| P/S | 1.23 | ||
| P/FCF | 16.52 | ||
| P/OCF | 12.67 | ||
| P/B | 1.55 | ||
| P/tB | 1.92 | ||
| EV/EBITDA | 10.17 |
EPS(TTM)7.98
EY8.09%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)5.97
FCFY6.05%
OCF(TTM)7.79
OCFY7.89%
SpS80.24
BVpS63.7
TBVpS51.42
PEG (NY)N/A
PEG (5Y)5.17
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.95% | ||
| ROE | 12.63% | ||
| ROCE | 6.17% | ||
| ROIC | 4.54% | ||
| ROICexc | 5.6% | ||
| ROICexgc | 6.81% | ||
| OM | 6.55% | ||
| PM (TTM) | 10.03% | ||
| GM | 38.4% | ||
| FCFM | 7.44% |
ROA(3y)5.58%
ROA(5y)5.02%
ROE(3y)8.42%
ROE(5y)7.86%
ROIC(3y)3.69%
ROIC(5y)4.24%
ROICexc(3y)4.66%
ROICexc(5y)5.54%
ROICexgc(3y)5.81%
ROICexgc(5y)6.31%
ROCE(3y)5.02%
ROCE(5y)5.77%
ROICexcg growth 3Y-14.56%
ROICexcg growth 5Y-0.52%
ROICexc growth 3Y-19.95%
ROICexc growth 5Y-4.34%
OM growth 3Y-18.96%
OM growth 5Y-4.08%
PM growth 3Y12.84%
PM growth 5Y-0.55%
GM growth 3Y-3.79%
GM growth 5Y-1.51%
F-Score4
Asset Turnover0.79
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.14 | ||
| Debt/FCF | 1.59 | ||
| Debt/EBITDA | 1.13 | ||
| Cap/Depr | 66.28% | ||
| Cap/Sales | 2.26% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 97.39% | ||
| Profit Quality | 74.21% | ||
| Current Ratio | 1.8 | ||
| Quick Ratio | 1.77 | ||
| Altman-Z | 3.37 |
F-Score4
WACC9.24%
ROIC/WACC0.49
Cap/Depr(3y)79.28%
Cap/Depr(5y)70.43%
Cap/Sales(3y)2.96%
Cap/Sales(5y)2.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)173.5%
EPS 3Y16.83%
EPS 5Y2.39%
EPS Q2Q%302.89%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.1%
Revenue growth 3Y3.55%
Revenue growth 5Y3.09%
Sales Q2Q%17.93%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y90%
EBIT growth 3Y-16.08%
EBIT growth 5Y-1.12%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y456.58%
FCF growth 3Y-22.84%
FCF growth 5Y3.94%
OCF growth 1Y875.16%
OCF growth 3Y-18.21%
OCF growth 5Y2.47%